| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17,778 |
12,698 |
$603K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
3,541 |
3,286 |
$559K |
| 59409 |
Vaginal delivery only (with or without episiotomy and/or forceps) |
749 |
735 |
$437K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,798 |
2,348 |
$134K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
907 |
890 |
$98K |
| 87481 |
|
1,237 |
1,164 |
$96K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
3,413 |
3,215 |
$91K |
| 59514 |
|
143 |
140 |
$90K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,415 |
3,210 |
$84K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
3,054 |
2,875 |
$79K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,237 |
1,191 |
$68K |
| 59430 |
|
740 |
718 |
$67K |
| 76801 |
|
628 |
605 |
$57K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
735 |
701 |
$57K |
| 76813 |
|
621 |
599 |
$57K |
| 87561 |
|
2,276 |
2,117 |
$56K |
| 81002 |
|
19,695 |
13,572 |
$55K |
| 87640 |
|
2,061 |
1,917 |
$53K |
| 87653 |
|
2,054 |
1,909 |
$53K |
| 81025 |
|
5,329 |
4,899 |
$36K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
524 |
513 |
$36K |
| 86409 |
|
335 |
302 |
$31K |
| 87511 |
|
1,166 |
1,095 |
$29K |
| 76830 |
Ultrasound, transvaginal |
241 |
235 |
$23K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
254 |
234 |
$18K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
206 |
176 |
$13K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
57 |
49 |
$10K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
118 |
117 |
$8K |
| 87625 |
|
143 |
138 |
$4K |
| 87186 |
|
105 |
100 |
$4K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
112 |
109 |
$3K |
| 99385 |
|
37 |
37 |
$3K |
| 87529 |
|
102 |
99 |
$3K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
26 |
25 |
$2K |
| 87532 |
|
105 |
103 |
$2K |
| 59025 |
Fetal non-stress test |
45 |
24 |
$2K |
| 87512 |
|
48 |
46 |
$1K |
| 87799 |
|
20 |
16 |
$954.82 |
| 80299 |
|
93 |
89 |
$789.58 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
59 |
53 |
$431.42 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
72 |
52 |
$266.56 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
16 |
13 |
$212.42 |
| 90461 |
|
18 |
16 |
$58.80 |
| 90647 |
|
34 |
27 |
$0.00 |
| 3008F |
|
1,015 |
833 |
$0.00 |
| 3074F |
|
798 |
669 |
$0.00 |
| 3079F |
|
42 |
38 |
$0.00 |
| 90680 |
|
56 |
44 |
$0.00 |
| 90723 |
|
20 |
19 |
$0.00 |
| 3075F |
|
23 |
20 |
$0.00 |
| 3078F |
|
543 |
450 |
$0.00 |
| 90670 |
|
56 |
45 |
$0.00 |